BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31099022)

  • 41. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
    Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
    Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.
    Miao CH; Nakai H; Thompson AR; Storm TA; Chiu W; Snyder RO; Kay MA
    J Virol; 2000 Apr; 74(8):3793-803. PubMed ID: 10729154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
    Nakai H; Thomas CE; Storm TA; Fuess S; Powell S; Wright JF; Kay MA
    J Virol; 2002 Nov; 76(22):11343-9. PubMed ID: 12388694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
    Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
    J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.
    Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA
    J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of
    Zhu H; Wang S; Li L; Geng W; Wan X; Hua R; Wang D; Gao P
    Front Pediatr; 2022; 10():1012825. PubMed ID: 36330364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
    Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
    Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variants.
    Huynh MT; Delaunay JL; Muller L; Corpechot C; Tran CT; Barbu V
    Rev Esp Enferm Dig; 2019 Jan; 111(1):76-79. PubMed ID: 30449124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
    Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
    Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
    Yeap SP; Harley H; Thompson R; Williamson KD; Bate J; Sethna F; Farrell G; Hague WB
    J Gastroenterol Hepatol; 2019 Feb; 34(2):425-435. PubMed ID: 29992621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.
    Harding TC; Dickinson PJ; Roberts BN; Yendluri S; Gonzalez-Edick M; Lecouteur RA; Jooss KU
    Hum Gene Ther; 2006 Aug; 17(8):807-20. PubMed ID: 16942441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel compound heterozygous mutation in ABCB4 gene in a pedigree with progressive familial intrahepatic cholestasis 3: a case report.
    Bai J; Li L; Liu H; Liu S; Bai L; Ning H; Song W; Zou H; Wang X; Chen Y; Zheng S; Duan Z
    Ann Transl Med; 2021 Mar; 9(5):426. PubMed ID: 33842647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AAV-Mediated Gene Delivery to the Mouse Liver.
    Cunningham SC; Alexander IE
    Methods Mol Biol; 2019; 1937():213-219. PubMed ID: 30706398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease.
    Sinha A; Bhuva M; Grant C; Gimson AE; Thompson E; Duckworth A; Davies SE; Aithal G; Griffiths WJ
    Dig Dis Sci; 2022 Dec; 67(12):5551-5561. PubMed ID: 35288833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
    Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
    J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver transplantation for decompensated liver cirrhosis caused by progressive familial intrahepatic cholestasis type 3: A case report.
    Xiang D; He J; Wang H; Xiong F; Cheng H; Ai J; Shan R; Wan R; Zhang L; Shi J
    Medicine (Baltimore); 2017 Dec; 96(50):e9158. PubMed ID: 29390323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The mechanism of biliary lipid secretion and its defects.
    Elferink RP; Groen AK
    Gastroenterol Clin North Am; 1999 Mar; 28(1):59-74, vi. PubMed ID: 10198778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.
    Khabou B; Mahjoub B; Barbu V; Balhoudi N; Wardani A; Sfar MT; Fakhfakh F
    Clin Chim Acta; 2018 Nov; 486():122-128. PubMed ID: 30036524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.